Nivolumab
treatment
6 mentions
2 recordings
first heard Oct 2024
last heard 19 Jun
↑2 vs the 12 months before
PD‑1 checkpoint inhibitor approved for bladder cancer therapy
Trend
Peak in the week of 15 Jun — 4 mentions across 1 series.
Moments
newest first · ▶ plays the momentJoseph ChanceDo you really know? · What are the latest advances in lung cancer treatment? · 2:55 · 19 Jun
…After a follow-up of 21 months or more, patients being treated with Nivolumab lived event-free for an extra 11 months on average, compared to those receiving chemotherapy alone.…
Joseph ChanceDo you really know? · What are the latest advances in lung cancer treatment? · 2:43 · 19 Jun
…The recent trial combined three cycles of Nivolumab with traditional chemotherapy prior to surgery.…
Joseph ChanceDo you really know? · What are the latest advances in lung cancer treatment? · 2:32 · 19 Jun
…And that's where Nivolumab comes in.…
6 moments · sign in to read them all